Pharmacodynamics of rocuronium 0.3 mg kg-1 in adult patients with and without renal failure

European Journal of Anaesthesiology

Volumn 22, Issue 12, 2005, Pages 929-932

  Robertson, E N ^a   Driessen, J J ^a   Vogt, M ^a   De Boer, H ^a   Scheffer, G J ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

Anaesthetics intravenous, propofol; Kidney failure chronic; Neuromuscular blockade, monitoring; Neuromuscular blocking agents, rocuronium

Indexed keywords

PROPOFOL; ROCURONIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ELECTROLYTE BALANCE; ENDOTRACHEAL INTUBATION; FEMALE; GENDER; HUMAN; INFORMED CONSENT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MALE; NEUROMUSCULAR FUNCTION; PROSPECTIVE STUDY; STATISTICAL ANALYSIS; ULNAR NERVE;

ADULT; ANDROSTANOLS; ANESTHESIA, INTRAVENOUS; ANESTHETICS, INTRAVENOUS; FEMALE; HUMANS; INTUBATION, INTRATRACHEAL; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PROPOFOL; TIME FACTORS;

EID: 28444456369     PISSN: 02650215     EISSN: 02650215     Source Type: Journal    
DOI: 10.1017/S0265021505001584     Document Type: Article

References (14)

1. Robertson EN, Driessen JJ, Booij LHDJ. Pharmacokinetics and pharmacodynamics of rocuronium in patients with and without renal failure. Eur J Anaesth 2005; 22: 4-10.
2. Khuenl-Brady KS, Pomaroli A, Pilhringer F, Mitterschiffthaler G, Koller J. The use of rocuronium in patients with chronic renal failure. Anaesthesia 1993; 48: 873-875.
3. Cooper RA, Maddineni VR, Mirakhur RK, Wierda JMHK, Brady M, Fitzpatrick KTJ. Time course of neuromuscular effects and pharmacokinetics of rocuronium bromide during isoflurane anaesthesia in patients with and without renal failure. Br J Anaesth 1993; 71: 222-226.
4. Szenohradsazky J, Fisher DM, Segredo V et al. Pharmacokinetics of rocuronium bromide in patients with normal renal function or patients undergoing cadaver renal transplantation. Anesthesiol 1992; 77: 899-904.
5. -1 in children with and without endstage renal failure. Ped Anesth 2002; 12: 507-510.
6. Lambalk LM, de Wit APM, Wierda JMKH, Hennis PJ, Agoston S. Dose-response relationship and time course of action of Org 9426. Anaesthesia 1991; 46: 907-911.
7. Eriksson LI. Evidence-based practice and neuromuscular monitoring and residual curarization: it's time for routine quantitative assessment. Anesthesiology 2003; 98: 1037-1039.
8. Kopman AF, Zank LM, Ng J, Neumann GG. Antagonism of cisatracurium and rocuronium block at a tactile train-of-four count of 2: Should quantitative assessment of neuromuscular function be mandatory? Anesth Analg 2004; 98: 102-106.
9. Barclay K, Eggers K, Asai T. Low-dose rocuronium improves conditions for tracheal intubation after induction of anaesthesia with propofol and alfentanil. Br J Anaesth 1997; 78: 92-94.
10. Prien T, Zahn P, Menges M, Brussel T. 1 x ED90 dose of rocuronium bromide: tracheal intubation conditions and time-course of action. Eur J Anaesthesiol Suppl 1995; 11: 85-90.
11. Eikermann M, Renzing-Kohler K, Peters J. Probability of acceptable intubation conditions with low dose rocuronium during light sevoflurane anaesthesia in children. Acta Anaesthesiol Scand 2001; 45: 1036-1041.
12. Miller RN, Sohn YJ, Matteo RS. Enhancement of D-tubocurarine neuromuscular blockade by diuretics in man. Anesthesiology 1976; 45: 442-445.
13. Durant NN, Nguyen N, Katz RL. Potentiation of neuromuscular blockade by Verapamil. Anesthesiology 1984; 60: 298-303.
14. Fischer JR, Baer RK. Acute myopathy associated with combined use of corticosteroids and neuromuscular blocking agents. Ann Pharmacother 1996; 30: 1437-1445.